rheumatoid-arthritis

Documents about rheumatoid-arthritis

• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines#865383ClinicalTrials.gov
• Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis#883636ClinicalTrials.gov
• A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis#886679ClinicalTrials.gov
• Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project#906968ClinicalTrials.gov
• Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.#1032658ClinicalTrials.gov
• Anatomical Shoulder Domelock System Study#810597ClinicalTrials.gov
• A Study of SPY072 in Rheumatic Disease#813217ClinicalTrials.gov
• 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity#865559ClinicalTrials.gov
• Patient Reported Outcomes Reported Via PC / Tablet Home Versus Touch Screen at Hospital Among Patients With Arthritis#314265ClinicalTrials.gov
• A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia#812066ClinicalTrials.gov
• Impact of Air Pollution on the Course of Inflammatory Rheumatism#831211ClinicalTrials.gov
• Mindfulness Based Stress Reduction in Rheumatic Diseases#837194ClinicalTrials.gov
• Monitoring the IMmUological TOXicity of Drugs#857429ClinicalTrials.gov
• The Chinese University of Hong Kong Early Arthritis Study#1046027ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy#863029ClinicalTrials.gov
• Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis#883940ClinicalTrials.gov
• Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases#897269ClinicalTrials.gov
• Personalized Outreach for Equitable Treatment in Rheumatology#859492ClinicalTrials.gov
• A Multiple Dose of HL237 in Healthy Male Subject#303709ClinicalTrials.gov
• Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan#825855ClinicalTrials.gov
• Tocilizumab Real-Life Human Factors (RLHFs) Validation Study#848015ClinicalTrials.gov
• Detection of Pathological Lymphocytes in Patients With Autoimmune Disease#857226ClinicalTrials.gov
• Ultrasound Utility in Routine Clinical Practise#878999ClinicalTrials.gov
• Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics#915034ClinicalTrials.gov
• Observational Study of Golimumab Intravenous Infusion#1045300ClinicalTrials.gov
• AdaBoost-based differential diagnosis of gouty arthritis and rheumatoid arthritis: model construction, temporal validation, and SHAP visualization.#457427NCBI PubMed Central
• Development and Evaluation of A Mailed Arthritis Self-Management Program#840701ClinicalTrials.gov
• Zimmer POLAR Persona - TKA (EMEA Study)#858041ClinicalTrials.gov
• Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study#870154ClinicalTrials.gov
• Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study#450664S-Space: Seoul National University
• RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis#800528ClinicalTrials.gov
• A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)#800820ClinicalTrials.gov
• Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)#908337ClinicalTrials.gov
• HLA-DRB1*07:01 and *08:02 alleles confer a protective effect against ACPA-positive rheumatoid arthritis in a latin american admixed population#935923Repositorio de Universidad Autónoma de Chile.
• Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC)#1044824ClinicalTrials.gov
• COMFI - a COMbined Fatigue Intervention#851926ClinicalTrials.gov
• Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old#471853HAL (France)
• Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents#873523ClinicalTrials.gov
• Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR)#882217ClinicalTrials.gov
• Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use#895250ClinicalTrials.gov
• COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases#912774ClinicalTrials.gov
• Effect Of CP-690,550 On The Pharmacokinetics Of Metformin In Healthy Volunteers#158159ClinicalTrials.gov
• Patient experiences of physical activity and exercise in rheumatoid arthritis#253939Enlighten Publications
• Sugar-Coded Signals: Glycan-Based Biomarkers in Rheumatoid Arthritis.#823571NCBI PubMed Central
• Scorpio Non Restricted Geometry (NRG) Study in Japan#825144ClinicalTrials.gov
• Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL#856384ClinicalTrials.gov
• REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations#898183ClinicalTrials.gov
• Exceed ABT Acetabular Cup Cementless System#966819ClinicalTrials.gov
• Novel therapeutic approaches for inflammation-induced bone loss : evaluation of the anti-inflammatory effect of Anti-ATX, curcumin and amaranth in a murine model of rheumatoid arthritis#388187HAL (France)
• Familial risks of hospital treated osteoporosis and fractures in first-, second- and third-degree relatives - A Swedish nationwide real-world family study#686589PLOS